KTALnews.com (KTAL/KMSS) – A wireless retinal implant is helping restore vision in patients with advanced age-related macular ...

Ocugen, Inc. (NASDAQ:OCGN) is one of the 11 Best High Volume Penny Stocks to Buy Now. On March 17, 2026, Canaccord initiated coverage of Ocugen, Inc. (NASDAQ:OCGN) with a Buy rating and a $12 price ...

Detailed price information for Krystal Biotech Inc (KRYS-Q) from The Globe and Mail including charting and trades.

Detailed price information for Krystal Biotech Inc (KRYS-Q) from The Globe and Mail including charting and trades.

Read this issue’s cover story titled “Specialists navigate changing, challenging landscape of geographic atrophy management.” More knowledge about the diagnosis and manageme ...

Metformin use in people with diabetes was linked to a significantly lower risk of developing intermediate age-related macular degeneration.

Enrollment spans Europe, the US, and Canada, targeting ~324 GA patients in a randomized, double-masked, sham-controlled phase 2 program. Dosing compares two intravitreal dose levels given every 12 or ...

Geographic atrophy management could benefit greatly from the combination of novel therapies and AI-driven imaging technology.

ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, today announced that the first European ...

Favorable early safety and initial efficacy data from BEST1 program highlighted at premier gathering of global retinal ...

Apellis (APLS) stock gains as Roth launches its coverage with a Buy rating and a $31 target, citing its lead asset Syfovre.